Compare GSK plc (GSK) vs Lennar Corporation (LEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Lennar Corporation — how do they compare? GSK plc trades at $50.5 (market cap $102.60B), while Lennar Corporation trades at $87.46 (market cap $21.05B). The key difference: GSK plc is far larger — about 4.9× Lennar Corporation's market cap, and GSK plc pays the higher dividend (3.57%). Which is the better fit depends on your goals.
| GSK | LEN | |
|---|---|---|
Market Cap | $102.60B | $21.05B |
Sector | Health | Consumer Cyclical |
52-Week High | $61.18 | $142.40 |
52-Week Low | $38.22 | $81.84 |
Enterprise Value | $123.04B | $24.93B |
Dividend Yield | 3.57% | 2.28% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Lennar Corporation
Lennar is the second-largest public homebuilder in the United States. The company's homebuilding operations target first-time, move-up, and active adult homebuyers mainly under the Lennar brand name. Lennar's financial-services segment provides mortgage financing and related services to its homebuyers. Miami-based Lennar is also involved in multifamily construction and has invested in numerous housing-related technology startups.
Read more on LEN →
